|
Volumn 24, Issue 6, 1999, Pages 622-627
|
S-28463. Treatment of hepatic C interferon inducer
a a
a
PROUS SCIENCE
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [4 AMINO 2 (ETHOXYMETHYL) 1H IMIDAZO[4,5 C]QUINOLIN 1 YL] 1,1 DIMETHYLETHANOL;
4 AMINO 2 (ETHOXYMETHYL) ALPHA,ALPHA 1H IMIDAZO[4,5 C]QUINOLINE 1 ETHANOL;
4 AMINO 2 ETHOXYMETHYL ALPHA,ALPHA DIMETHYL 1H IMIDAZOL[4,5 C]QUINOLINE 1 ETHANOL;
ALPHA INTERFERON;
ANTISENSE OLIGODEOXYNUCLEOTIDE;
ANTIVIRUS AGENT;
CLEVUDINE;
CONSENSUS INTERFERON;
CPG 7909;
EMTRICITABINE;
ENTECAVIR;
FLAVONE DERIVATIVE;
HEPATITIS B ANTIBODY;
HISTAMINE DERIVATIVE;
IMIQUIMOD;
INTERFERON INDUCING AGENT;
ISIS 14803;
MACROGOL;
MAXAMINE;
MERIMEPODIB;
NABI 3700001;
NABI CIVACIR;
NUCLEOSIDE ANALOG;
PEG INTRON A;
PEGINTERFERON ALPHA2A;
POLYCLONAL ANTIBODY;
PROTEINASE INHIBITOR;
REBETRON;
RECOMBINANT ALPHA2B INTERFERON;
RESIQUIMOD;
RIBAVIRIN;
RO 326167;
ROBUSTAFLAVONE;
THYMOSIN ALPHA1;
TUVIRUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VP 14637;
VRT 21493;
WO 9743310;
WO 9817679;
WO 9822496;
XTL 001;
ARTICLE;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HEPATITIS C;
HUMAN;
NONHUMAN;
|
EID: 0032770689
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.1999.024.06.489138 Document Type: Article |
Times cited : (4)
|
References (19)
|